Literature DB >> 198555

Cell proliferation and histologic classification of bronchogenic carcinoma.

B Hainau, P Dombernowsky, H H Hansen, S Borgeskov.   

Abstract

The rate of cell proliferation of 99 bronchogenic carcinomas (94 primary tumors and 5 metastases) was evaluated from the labeling index after in vitro incorporation of [3H]thymidine; the rate was then correlated with the histologic tumor type according to the classification of the World Health Organization (WHO). Cell proliferation was significantly slower in adenocarcinoma (WHO type III) than in squamous cell carcinoma (WHO type I), small cell anaplastic carcinoma (WHO type II), and large cell carcinoma (WHO type IV). Cells proliferated at a significantly higher rate in large cell carcinoma than in the squamous cell type, whereas no significant difference was observed between the other cell types. Dedifferentiated forms of squamous cell carcinomas had a higher rate of cell proliferation than did differentiated forms of the same cell type. Metastases of small cell anaplastic carcinoma did not differ in cell proliferation from primary tumors of the same cell type.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 198555     DOI: 10.1093/jnci/59.4.1113

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  4 in total

1.  New approach to assessing lung tumours in man.

Authors:  K C Gatter; M S Dunnill; J Gerdes; H Stein; D Y Mason
Journal:  J Clin Pathol       Date:  1986-06       Impact factor: 3.411

Review 2.  Small cell anaplastic carcinoma of the lung. A review of growth characteristics and implications for chemotherapy.

Authors:  B A Brigham
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  Considering lead-time bias in evaluating the effectiveness of lung cancer screening with real-world data.

Authors:  Szu-Chun Yang; Jung-Der Wang; Shi-Yi Wang
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

4.  In vitro thymidine labelling of human pulmonary neoplasms.

Authors:  K M Kerr; A M Robertson; D Lamb
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.